Ingersoll Rand Inc.·4

Feb 19, 6:31 PM ET

Hepding Elizabeth Meloy 4

4 · Ingersoll Rand Inc. · Filed Feb 19, 2026

Research Summary

AI-generated summary of this filing

Updated

Ingersoll Rand (IR) SVP Elizabeth Hepding Exercises Options, Sells Shares

What Happened Elizabeth Meloy Hepding, Senior Vice President, Corporate Development at Ingersoll Rand (IR), exercised 18,246 stock options on Feb 17, 2026 (exercise price $49.52, cost $903,542) and sold the 18,246 shares the same day in an open-market transaction at $97.11 per share for proceeds of $1,771,869. The filing also records a derivative conversion/disposition entry at $0 associated with the option exercise.

Key Details

  • Transaction date: 2026-02-17 (Form filed 2026-02-19; appears timely)
  • Exercise: 18,246 shares @ $49.52 = $903,542 (transaction code M)
  • Sale: 18,246 shares @ $97.11 = $1,771,869 (transaction code S)
  • Net difference (gross proceeds minus exercise cost): ~$868,327 (before taxes/fees)
  • Footnote: F1 — the options exercised were fully vested and exercisable
  • Shares owned after transaction: not specified in the provided filing excerpt
  • No 10b5-1 plan or tax-withholding specifics disclosed in the available data

Context Because the options were exercised and the resulting shares were sold the same day, this is effectively a cashless exercise (exercise followed by immediate sale to realize proceeds and cover exercise cost/taxes). Sales by executives are common for liquidity and do not necessarily indicate a change in view on the company; purchases are generally more informative about insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-17
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-17$49.52/sh+18,246$903,54234,446 total
  • Sale

    Common Stock

    2026-02-17$97.11/sh18,246$1,771,86916,200 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    [F1]
    2026-02-1718,2460 total
    Exercise: $49.52Exp: 2031-08-09Common Stock (18,246 underlying)
Footnotes (1)
  • [F1]These stock options are fully vested and exercisable.
Signature
/s/ Andrew Schiesl, as Attorney-in-Fact|2026-02-19

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4